Search clinical trials for: Cancro

Total 53755 results

MedImmune LLC

Completed

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Prostate Cancer

United States, Belgium, Israel, Russian Federation, Canada, Hungary, Poland
Seoul National University Hospital

Unknown

Systemic Consolidation Therapy After Primary Chemoradiation Therapy for Locally Advanced Cervical Cancer

Cervical Cancer

Korea, Republic of
Seoul National University Hospital

Unknown

Systemic Consolidation Therapy After Chemoradiation Therapy Following Operation for High Risk Early Stage Cervical Cancer

Cervical Cancer

Korea, Republic of
Hospital of Navarra
Dr. Enrique Martínez López

Unknown

Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Spain
University of Michigan Rogel Cancer Center
Hoffmann-La Roche

Terminated

Radiation Therapy With Capecitabine in Rectal Cancer

Rectal Cancer

United States
University of Milan
Fondazione Humanitas per la Ricerca

Completed

Alternative to Two-Stage Hepatectomy

Colorectal Cancer | Liver Metastases

Italy
NSABP Foundation Inc
Amgen

Withdrawn

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum

Neoplasm Metastasis | Rectal Cancer
Herlev Hospital

Terminated

Dendritic Cell Based Therapy of Metastatic Breast Cancer

Metastatic Breast Cancer

Denmark
Massachusetts General Hospital
Eli Lilly and Company; GlaxoSmithKline

Completed

Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States
University of California, Davis

Completed

Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance. (GCP)

Prostate Cancer
Astellas Pharma Inc

Completed

LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

Lung Cancer | Carcinoma, Non-Small Cell Lung | Cancer of Lung | Non-Small Cell Lung Carcinoma | Cancer of the Lung

Germany, Czech Republic, Netherlands
University of California, Davis

Completed

Diet, Genetic Variation and Prostate Cancer Among African Americans

Prostate Cancer
The Netherlands Cancer Institute
Dutch Cancer Society

Unknown

Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial (EVA project)

Menopausal Symptoms in Breast Cancer Patients With Treatment-Induced Complaints
Dana-Farber Cancer Institute
Boston Children's Hospital

Terminated

rhEndostatin Protein Involving Pediatric Patients With Cancer

Solid Tumors

United States
University Hospital, Ghent

Completed

EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer

Lung Cancer

Belgium
University Hospital, Ghent

Completed

High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study

Advanced Colorectal Cancer

Belgium
Amgen

Completed

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

Anemia | Non-Small Cell Lung Cancer
Amgen

Completed

ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

Neoplasm Metastasis | Non-Small Cell Lung Cancer | Lung Cancer
Maxygen Holdings Ltd.
Parexel; Maxygen ApS; Maxygen, Inc.

Unknown

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Breast Cancer | Chemotherapy-Induced Neutropenia

Poland, Romania, Russian Federation, Ukraine
Cell Genesys

Completed

A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung | Lung Cancer
Amgen

Completed

Treatment for Patients Suffering From Anemia Due to Chemotherapy

Breast Cancer | Anemia
Cell Genesys

Completed

Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

Prostate Cancer

United States
Cell Genesys

Completed

Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma

Multiple Myeloma

United States
Amgen

Completed

Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy

Genital Neoplasms, Female | Anemia | Gynecological Malignancies
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Terminated

High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma

Breast Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma

Colorectal Adenocarcinoma

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; United... and other collaborators

Completed

Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy

Breast Cancer | Menopause | Postmenopausal Bone Loss

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaborators

Completed

Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer

Neoplasm Metastasis | Colorectal Cancer

United States
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center; Brigham and Women's Hospital

Completed

Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer

Breast Cancer | Metastatic Breast Cancer

United States
Cytogen Corporation

Unknown

Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

Prostatic Neoplasms

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Eli Lilly and Company; Beth Israel Deaconess... and other collaborators

Completed

Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer

Biliary Tract Cancer | Gallbladder Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaborators

Completed

Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Breast Cancer

United States
Epeius Biotechnologies

Terminated

Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer

Pancreatic Cancer

United States
AstraZeneca

Completed

Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma

Head and Neck Cancer

Hong Kong, Singapore
AstraZeneca

Completed

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

Non-Small Cell Lung Cancer

France
AstraZeneca

Completed

ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer

Non Small Cell Lung Carcinoma

Australia
Unither Pharmaceuticals

Terminated

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Ovarian Cancer
AstraZeneca

Completed

A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

Colorectal Cancer

Spain
AstraZeneca

Completed

Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer

Metastatic Breast Cancer

Norway
AstraZeneca

Completed

Quetiapine Augmentation in Severe Obsessive Compulsive Disorder

Obsessive Compulsive Disorder

Germany
Unither Pharmaceuticals

Terminated

Clinical Trial for Ovarian Cancer (OvaRex®)

Ovarian Cancer

United States
AstraZeneca

Completed

Iressa 2nd Line Phase III Study in Japan

Non-Small Cell Lung Cancer

Japan
Memorial Sloan Kettering Cancer Center
Fordham University

Completed

Psychostimulants for Fatigue in Prostate Cancer

Fatigue | Prostate Cancer

United States
University of Washington
Aventis Pharmaceuticals

Completed

Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer

Breast Neoplasm

United States
Attenuon

Terminated

ATN-161 in Advanced Renal Cell Cancer

Carcinoma, Renal Cell

United States
Eli Lilly and Company

Completed

A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer

Breast Cancer

Brazil, Greece, Hungary, Peru, Poland, Spain, Venezuela
Abbott

Completed

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

Breast Cancer

United States
Abbott

Completed

A Long Term Safety Study With Atrasentan

Adenocarcinoma | Prostate Cancer

Canada, United States, France, Netherlands, United Kingdom
University of Washington
Sanofi

Completed

Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer

Prostate Cancer

United States

Search clinical trials for: Cancro

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations